Antiepileptic drugs and lipid-lowering agents in surface water in Colombia: occurrence, ecological threat, and removal strategies

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Environmental science and pollution research international

• Publication date

  2025-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s11356-025-36890-7PMID 40921983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Trends in Antidepressant Consumption: a 10-year Comparative Analysis (2010–2020)

  2025cited by this paper
• Assessment of the Presence of Transformation Products of Certain Pharmaceutical Products (Psychotropic Family) by Suspect and Non-Targeted HRMS Screening in Wastewater Treatment Plants

  2023cited by this paper
• Removal of pharmaceutical compounds from real urban wastewater by a continuous bio-electrochemical process at pilot scale

  2023cited by this paper
• Antiepileptic drugs in aquatic environments: Occurrence, toxicity, transformation mechanisms and fate

  2023cited by this paper
• Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review

  2023cited by this paper
• Comparative analysis of the removal and transformation of 10 typical pharmaceutical and personal care products in secondary treatment of sewage: a case study of two biological treatment processes

  2022cited by this paper
• From monitoring to treatment, how to improve water quality: the pharmaceuticals case

  2022influential reference
• Oxidative stress and metal homeostasis alterations in Danio rerio (zebrafish) under single and combined carbamazepine, acetamiprid and cadmium exposures.

  2022influential reference
• Residues of Selected Anticonvulsive Drugs in Surface Waters of the Elbe River Basin (Czech Republic)

  2022cited by this paper
• Derivation of Water Quality Criteria for Carbamazepine and Ecological Risk Assessment in the Nansi Lake Basin

  2022cited by this paper
• Occurrence, hazard, and risk of psychopharmaceuticals and illicit drugs in European surface waters.

  2022cited by this paper
• Sustainable adsorbents for the removal of pharmaceuticals from wastewater: A review.

  2022cited by this paper
• Occurrence of emerging contaminants in highly anthropogenically influenced river Yamuna in India.

  2021cited by this paper
• Antiepileptic Drugs: From Public to Environmental Health Problem

  2021cited by this paper
• Application of water quality index and multivariate statistical techniques for assessment of water quality around Yamuna River in Agra Region, Uttar Pradesh, India

  2021cited by this paper
• Human Drug Pollution in the Aquatic System: The Biochemical Responses of Danio rerio Adults

  2021cited by this paper
• Emerging contaminants in wastewater: A critical review on occurrence, existing legislations, risk assessment, and sustainable treatment alternatives

  2021cited by this paper
• Productos farmacéuticos y de cuidado personal presentes en aguas superficiales, de consumo humano y residuales en el departamento de Córdoba, Colombia

  2021cited by this paper
• Pharmaceuticals and environmental risk assessment in municipal wastewater treatment plants and rivers from Peru.

  2021influential reference
• Ecotoxicological effects, environmental fate and risks of pharmaceutical and personal care products in the water environment: A review.

  2021cited by this paper
• Occurrence and health risk assessment of pharmaceutically active compounds in riverbank filtrated drinking water

  2021influential reference
• A review of antiepileptic drugs: Part 1 occurrence, fate in aquatic environments and removal during different treatment technologies.

  2021cited by this paper
• Effects of chronic exposure to carbamazepine on hematological parameters in Cyprinus carpio

  2020cited by this paper
• Assessment of nutrient enrichment and heavy metal pollution of headwater streams of Bulawayo, Zimbabwe

  2020influential reference
• Occurrence of pharmaceuticals, hazard assessment and ecotoxicological evaluation of wastewater treatment plants in Costa Rica.

  2020cited by this paper
• High-rate algal pond for removal of pharmaceutical compounds from urban domestic wastewater under tropical conditions. Case study: Santiago de Cali, Colombia.

  2020cited by this paper
• Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug products.

  2020cited by this paper
• Occurrence and removal of pharmaceutical and personal care products using subsurface horizontal flow constructed wetlands.

  2020influential reference
• Occurrence and risk assessment of pharmaceutically active compounds in water supply systems in Brazil.

  2020cited by this paper
• Occurrence and transformation of gabapentin in urban water quality engineering: Rapid formation of nitrile from amine during drinking water chlorination.

  2020cited by this paper
• Occurrence and spatial distribution of statins, fibrates and their metabolites in aquatic environments

  2020influential reference
• Pharmaceuticals in aquatic environment. Fate and behaviour, ecotoxicology and risk assessment – A review

  2019cited by this paper
• Environmentally-related contaminants of high concern: Potential sources and analytical modalities for detection, quantification, and treatment.

  2019cited by this paper
• Short-term exposure to carbamazepine causes oxidative stress on common carp (Cyprinus carpio).

  2019cited by this paper
• Pharmaceutical emerging pollutants removal from water using powdered activated carbon: Study of kinetics and adsorption equilibrium.

  2019cited by this paper
• Aquatic Ecosystem and Biodiversity: A Review

  2019cited by this paper
• Optimization of screening-level risk assessment and priority selection of emerging pollutants - The case of pharmaceuticals in European surface waters.

  2019cited by this paper
• Influence of water depth and season on the photodegradation of micropollutants in a free-water surface constructed wetland receiving treated wastewater.

  2019cited by this paper
• Occurrence, fate and removal of pharmaceutically active compounds (PhACs) in water and wastewater treatment plants—A review

  2019cited by this paper
• Health at a Glance 2019

  2019cited by this paper
• Biotransformation of carbamazepine by laccase-mediator system: Kinetics, by-products and toxicity assessment

  2018cited by this paper
• Effects of trophic status, water level, and temperature on shallow lake metabolism and metabolic balance: A standardized pan‐European mesocosm experiment

  2018cited by this paper
• Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment.

  2018cited by this paper
• Chronic effects of carbamazepine on zebrafish: Behavioral, reproductive and biochemical endpoints.

  2018cited by this paper
• Removal of pharmaceuticals and personal care products from domestic wastewater using rotating biological contactors

  2018cited by this paper
• Biotransformation of gabapentin in surface water matrices under different redox conditions and the occurrence of one major TP in the aquatic environment.

  2018cited by this paper
• Carbamazepine as a Possible Anthropogenic Marker in Water: Occurrences, Toxicological Effects, Regulations and Removal by Wastewater Treatment Technologies

  2018cited by this paper
• 'An investigation into the occurrence and removal of pharmaceuticals in Colombian wastewater'.

  2018influential reference
• Temporal and spatial variation in pharmaceutical concentrations in an urban river system.

  2018cited by this paper
• Water quality, pollutant loads, and multivariate analysis of the effects of sewage discharges into urban streams of Southeast Brazil

  2017cited by this paper
• UHPLC-QTOF MS screening of pharmaceuticals and their metabolites in treated wastewater samples from Athens.

  2017cited by this paper
• Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment

  2017cited by this paper
• Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle.

  2017cited by this paper
• Acidic, neutral and alkaline forest ponds as a landscape element affecting the biodiversity of freshwater snails

  2017cited by this paper
• Biodegradation of carbamazepine using freshwater microalgae Chlamydomonas mexicana and Scenedesmus obliquus and the determination of its metabolic fate.

  2016cited by this paper
• Low environmental levels of neuro-active pharmaceuticals alter phototactic behaviour and reproduction in Daphnia magna.

  2016cited by this paper
• Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters

  2015influential reference
• Quantitative target and systematic non-target analysis of polar organic micro-pollutants along the river Rhine using high-resolution mass-spectrometry--Identification of unknown sources and compounds.

  2015cited by this paper
• Validation of an ultra high performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of 19 endocrine disruptors in milk

  2015cited by this paper
• Enhanced removal of naproxen and carbamazepine from wastewater using a novel countercurrent seepage bioreactor immobilized with Phanerochaete chrysosporium under non-sterile conditions.

  2015cited by this paper
• Occurrence and fate of select psychoactive pharmaceuticals and antihypertensives in two wastewater treatment plants in New York State, USA.

  2015cited by this paper
• Integrating organic micropollutant removal into tertiary filtration: Combining PAC adsorption with advanced phosphorus removal.

  2015cited by this paper
• Occurrence and removal of frequently prescribed pharmaceuticals and corresponding metabolites in wastewater of a sewage treatment plant.

  2015influential reference
• PBT assessment and prioritization by PBT Index and consensus modeling: comparison of screening results from structural models.

  2015cited by this paper
• Critical predicted no effect concentrations (PNECs) should not be based on a single toxicity test

  2015cited by this paper
• Concentration evolution of pharmaceutically active compounds in raw urban and industrial wastewater.

  2014cited by this paper
• Suppression of Methane Gas Emissions and Analysis of the Electrode Microbial Community in a Sediment-Based Bio-Electrochemical System

  2014influential reference
• Assessment of multi-chemical pollution in aquatic ecosystems using toxic units: compound prioritization, mixture characterization and relationships with biological descriptors.

  2014cited by this paper
• Use of antiepileptic drugs and lipid-lowering agents in the United States.

  2014cited by this paper
• Interacciones medicamentosas de agentes hipolipemiantes: aproximación para establecer y valorar su relevancia clínica. Revisión estructurada

  2013cited by this paper
• [Hypolipidemic agents drug interactions: approach to establish and assess its clinical significance. Structured review].

  2013cited by this paper
• Widespread occurrence of neuro-active pharmaceuticals and metabolites in 24 Minnesota rivers and wastewaters.

  2013cited by this paper
• Global Synthesis and Critical Evaluation of Pharmaceutical Data Sets Collected from River Systems

  2012cited by this paper
• Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the Haihe River Basin, China.

  2011cited by this paper
• Critical oxygen levels and metabolic suppression in oceanic oxygen minimum zones

  2011influential reference
• Determination of Antibiotics in Brazilian Surface Waters Using Liquid Chromatography–Electrospray Tandem Mass Spectrometry

  2011cited by this paper
• Emerging pollutants in wastewater: a review of the literature.

  2011cited by this paper
• Persistence of gemfibrozil, naproxen and mefenamic acid in natural waters

  2011cited by this paper
• Recent advances in environmental risk assessment of transformation products.

  2011cited by this paper
• Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.

  2010cited by this paper
• Potential application of ecological models in the European environmental risk assessment of chemicals I: Review of protection goals in EU directives and regulations

  2010cited by this paper
• Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.

  2009cited by this paper
• Environmental pollution by antibiotics and by antibiotic resistance determinants.

  2009cited by this paper
• Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.

  2009cited by this paper
• Understanding the influence of suspended solids on water quality and aquatic biota.

  2008cited by this paper
• Toxic and genotoxic impact of fibrates and their photoproducts on non-target organisms.

  2007cited by this paper
• Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments.

  2006cited by this paper
• The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus.

  2005cited by this paper
• Human Pharmaceuticals in Wastewater Treatment Processes

  2005influential reference
• Pharmaceutical data elude researchers.

  2005cited by this paper
• Phototransformation of fibrate drugs in aqueous media

  2005cited by this paper
• Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac.

  2003cited by this paper
• Waterborne and sediment toxicity of fluoxetine to select organisms.

  2003cited by this paper
• Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?

  2003cited by this paper
• Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry.

  2003cited by this paper
• Standard methods for the examination of water and waste water.

  1966cited by this paper

• No citing papers are available for this paper.